Cornerstone Advisors (Washington)’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
$2K Buy
74
+20
+37% +$541 ﹤0.01% 613
2020
Q2
$1K Hold
54
﹤0.01% 695
2020
Q1
$1K Hold
54
﹤0.01% 733
2019
Q4
$1K Buy
+54
New +$1K ﹤0.01% 738